» Authors » Deirdre Cronin-Fenton

Deirdre Cronin-Fenton

Explore the profile of Deirdre Cronin-Fenton including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 93
Citations 1304
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Vesteghem C, Bogsted M, Cronin-Fenton D, Ostergaard Poulsen L
Clin Epidemiol . 2024 Mar; 16:165-174. PMID: 38476264
Background: Reconstructing patient treatment trajectories is important to generate real-world evidence for epidemiological studies. The Danish National Patient Registry (DNPR) contains information about drug prescriptions and could therefore be used...
12.
Geurts F, Chaker L, van der Burgh A, Cronin-Fenton D, Fenton R, Hoorn E
J Am Heart Assoc . 2024 Feb; 13(4):e032835. PMID: 38362883
Background: Inhibition of prostaglandin synthesis by nonsteroidal anti-inflammatory drugs is associated with cardiovascular mortality and kidney disease. This study hypothesizes that urinary prostaglandin E2 (PGE2) and PGE2 metabolite (PGEM) excretions...
13.
Amdisen L, Pedersen L, Abildgaard N, Benn C, Rorth M, Cronin-Fenton D, et al.
Vaccine . 2024 Feb; 42(7):1690-1697. PMID: 38350769
Background: Influenza vaccination is recommended and provided free-of-charge to Danish citizens aged ≥65 years and to individuals with acquired immunodeficiency. We aimed to estimate influenza vaccination coverage and investigate predictors...
14.
Kirkegard J, Gaber C, Heide-Jorgensen U, Fristrup C, Lund J, Cronin-Fenton D, et al.
J Natl Cancer Inst . 2024 Feb; 116(7):1072-1079. PMID: 38310365
Background: To estimate the causal effect of surgery vs chemotherapy on survival in patients with T1-3NxM0 pancreatic cancer in a rigorous framework addressing selection bias and immortal time bias. Methods:...
15.
Kirkegard J, Cronin-Fenton D, Lund A, Mortensen F
Pharmacoepidemiol Drug Saf . 2023 Nov; 33(1):e5726. PMID: 37946571
Purpose: We examined the association between use of beta-blockers and survival in pancreatic cancer patients after curative-intent surgery. Methods: Using Danish healthcare registries, we conducted a population-based cohort study of...
16.
Harborg S, Cronin-Fenton D, Jensen M, Ahern T, Ewertz M, Borgquist S
JAMA Netw Open . 2023 Oct; 6(10):e2337780. PMID: 37831449
Importance: Clinical studies confirm that obesity is a risk factor for recurrence in postmenopausal women with hormone receptor-positive (HR+) breast cancer. Evidence suggests that women with obesity do not obtain...
17.
Jordt N, Kjaergaard K, Thomsen R, Borgquist S, Cronin-Fenton D
Breast Cancer Res Treat . 2023 Sep; 202(1):11-22. PMID: 37656235
Purpose: Breast cancer and its treatments may increase the risk of type 2 diabetes (T2D). We conducted a systematic review and meta-analysis to investigate the association between breast cancer and...
18.
Hjorth C, Damkier P, Ejlertsen B, Lash T, Sorensen H, Cronin-Fenton D
BMC Med . 2023 Aug; 21(1):311. PMID: 37592309
No abstract available.
19.
Harborg S, Kjaergaard K, Thomsen R, Borgquist S, Cronin-Fenton D, Hjorth C
J Clin Endocrinol Metab . 2023 Aug; 109(4):924-935. PMID: 37552777
The global prevalence of obesity and diabetes mellitus has increased in parallel with increasing cancer incidence, due to environmental and lifestyle factors and population aging. Metabolic diseases are associated with...
20.
Harborg S, Feldt M, Cronin-Fenton D, Klintman M, Dalton S, Rosendahl A, et al.
Cancer Metab . 2023 Jun; 11(1):8. PMID: 37370158
Purpose: Examine the association between obesity and clinical outcomes in early breast cancer and assess if patient, tumor, and treatment characteristics modify such associations in Malmö Diet and Cancer Study...